5-Hydroxytryptamine releases adenosine from primary afferent nerve terminals in the spinal cord

Marva Sweeney, Thomas White, Jana Sawynok

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

5-Hydroxytryptamine (serotonin, 5-HT) increased the release of endogenous adenosine from dorsal, but not ventral, spinal cord synaptosomes. This release was reduced by (i) the 5-HT receptor antagonist methysergide, (ii) removal of Ca2+ from the medium, (iii) inhibition of ecto-5′-nucleotidase and (iv) capsaicin pretreatment. These data suggest that activation of 5-HT receptors on primary afferent terminals releases a nucleotide which is converted extracellularly to adenosine. This adenosine may contribute to the spinal antinociceptive effect of 5-HT.

Original languageEnglish
Pages (from-to)346-349
Number of pages4
JournalBrain Research
Volume462
Issue number2
DOIs
Publication statusPublished - Oct 18 1988

Bibliographical note

Funding Information:
This work was supported by the Medical Research Council of Canada in grants to T.W. and J.S.

ASJC Scopus Subject Areas

  • General Neuroscience
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Fingerprint

Dive into the research topics of '5-Hydroxytryptamine releases adenosine from primary afferent nerve terminals in the spinal cord'. Together they form a unique fingerprint.

Cite this